Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA06
- Pharmacological subgroupA06A
- Chemical subgroupA06AXOther laxatives
- Chemical substanceA06AX04Linaclotide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 3 registrations
United States
FDA · 2 registrations
Spain
AEMPS · 1 registration
European Union
At a glance
- ATC code
- A06AX04
- ATC group
- Alimentary tract and metabolism
- Registers
- 6
- Historical lists
- 1
- Registrations
- 10
- With their own page
- 8
- Companies
- 5
All medicines with Linaclotide
Human medicines from every register that match Linaclotide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
10 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Linzess | United States | 145MCG, 290MCG, 72MCG | capsule | Marketed | Abbvie |
| Constella | European Union | Authorised | AbbVie Deutschland GmbH & Co. KG | ||
| Constella 290 microgramos capsulas duras | Spain | 0,290 mg | cápsula dura | Marketed | Abbvie Deutschland Gmbh & Co. Kg |
| Constella 290 microgram harde capsules | Netherlands | Capsule, hard | Authorised | AbbVie Deutschland GmbH & Co. KG | |
| Constella | Canada | 72 MCG | Capsule | Marketed | Abbvie Corporation |
| Constella | Canada | 290 MCG | Capsule | Marketed | Abbvie Corporation |
| Constella | Canada | 145 MCG | Capsule | Marketed | Abbvie Corporation |
| Constella | Croatia | Authorised | |||
| Linzess | Saudi Arabia | Authorised | Forest Laboratories Ireland Limited | ||
| Linaclotide | United States | 145MCG, 290MCG, 72MCG | capsule | Tentative approval | Actavis Labs FL INC |